|
|
The ECA RMM Working Group will be lead by a Chairman and 6 Charter Members:
Chairman:
Board Members:
-
Peter Ball,
Pall Life Sciences 
-
Barbara Gerten, Merck KGaA 
-
Dr Klaus Haberer, Compliance Advice and Services in
Microbiology 
-
Dr Ulrich Herber, Accugenix 
-
Dr Thomas Lukow, Novartis Vaccines and Diagnostics 
-
Dr Thomas Mikosch, Centocor
-
Dr Thomas Montag, German Federal Agency for Sera and
Vaccines
-
Dr Paul Newby, GlaxoSmitKline
-
Dr Sébastien Ribault,
MILLIPORE S.A.S.

|
|